UBS cuts Eversource Energy stock price target on FERC ROE reduction

FERC set a new base ROE for New England transmission at 9.57% (down 100 bps from 10.57%), producing an immediate annualized EPS headwind of about $0.19 and prompting UBS to cut its Eversource price target to $74 (from $80) while keeping Neutral. Eversource reported Q4 2025 non‑GAAP EPS of $1.12 (vs $1.01) and full‑year EPS of $4.76 (vs $4.57), and has raised its dividend for the 27th consecutive year, yielding roughly 4.6%. Connecticut approved the Aquarion sale for ~$2.4B (with ~$800M allocated to reduce Aquarion debt); regulatory appeals and refund timing remain unresolved, creating near‑term regulatory uncertainty that could pressure valuation and analyst targets.

Analysis

Regulatory ratemaking risk has become the dominant driver of near-term equity volatility for transmission-heavy utilities. A modest move in allowed ROE (tens of basis points) compounds through rate base multipliers and refund mechanics, producing earnings and equity-value swings that can be non-linear if refunds are retroactive; modelers should stress-test both timing and refund duration independently rather than folding them into a single ROE sensitivity.

Second-order winners will be entities that can deploy the cash proceeds or lower leverage from asset disposals quickly — private infrastructure buyers and water/regulatory-friendly buyers will be able to bid accretively if they price in a lower short-term regulatory yield but longer-term stable cash flows. Conversely, transmission-only owners and contractors reliant on steady approval timing will face margin and working-capital pressure as projects are delayed or re-scoped; that creates a window for selective shorts in pure-transmission profiles.

Key catalyst timing: administrative appeals and interregional rulings (including MISO) clustered into the next 3–9 months, and state-level approvals for asset transfers over the same horizon, will create episodic repricing; a court or FERC decision that narrows refund windows would quickly reverse the move, while an adverse judicial interpretation extending refunds could produce multi-quarter earnings hits and potential credit-rating action. Prepare for binary moves around filings and quarterly disclosures and run scenarios where refunds extend beyond management accruals.

The market is treating this as primarily a regulatory story, but capital allocation response (debt reduction, buyback crimping, dividend preservation) is the operational channel that determines real shareholder pain. Watch liquidity and covenant headroom — if management pivots to prioritize credit over distributions, the equity re-rating could be gradual; if they defend payouts, downside becomes concentrated and sharper.

Key Decisions for Investors

• Pair trade (3–12 months): Short ES 1.0x notional / Long NEE 1.0x notional. Thesis: ES stands to underperform if regulatory refund risk crystallizes while NEE’s growth/merchant earnings are less ROE-sensitive. Target: 15–25% relative outperformance; stop-loss: cut if ES outperforms by 8% relative to NEE.
• Hedge / asymmetric bearish options (6–12 months): Buy ES 6–12 month put spread — long strike ~-22% from spot, short strike ~-38% from spot (size to cap premium ~0.5–1.0% of portfolio). Rationale: caps premium while capturing large adverse regulatory outcome; max loss = premium, max gain ~3–6x premium depending on strikes.
• Event trade (days–weeks around filings): Reduce gross exposure into any FERC/court filing windows and increase cash or buy short-dated protection. If an appeals court issues favorable language (narrowing refund scope), add back long ES exposure quickly; if not, add to puts or widen short position.
• Contrarian buy (12–36 months): If management uses asset-sale proceeds to materially deleverage and establishes clear dividend coverage guidance, consider initiating a long position in ES sized for a 30–40% upside over 24–36 months. Risk: regulatory reversals or prolonged refund payments; require covenant/headroom improvement as a buy trigger.